"I rekon It could all happen faster than we think" - OK then.
Even a treatment that has “the potential to change the current treatment paradigm for heart attack survivors and improve global health outcomes for the millions of people at risk for early recurrent cardiovascular events.” is going to take four years for Phase3 and another couple for NDA and to market, minimum six years all up and at a cost of $724,000,000.
I'll let CSL know they're going seriously wrong somewhere.
Add to My Watchlist
What is My Watchlist?
